Literature DB >> 3918341

Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia.

K G Schmidt, J W Rasmussen, C Bekker, P E Madsen.   

Abstract

The kinetics and distribution in vivo of autologous 111-In-labelled platelets were studied in 20 patients with chronic hepatic disease. The patients, 16 of whom were thrombocytopenic, exhibited a shortened platelet mean life time, a reduced platelet recovery and a normal platelet turnover, the latter 2 of which were positively correlated to the platelet count. Platelet in vivo recovery was negatively correlated to the spleen volume. In accordance with this, scintigraphic studies revealed that the spleen was the major organ of platelet sequestration and destruction, the role of the liver being almost negligible. Signs of platelet destruction in the bone marrow were also found. Our results indicate that splenic platelet pooling and accelerated platelet destruction, accompanied by inability of the bone marrow to compensate for the thrombocytopenia are the main causes of the thrombocytopenia accompanying chronic hepatic disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918341     DOI: 10.1111/j.1600-0609.1985.tb00742.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  12 in total

1.  Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly.

Authors:  Kazuaki Tejima; Ryota Masuzaki; Hitoshi Ikeda; Haruhiko Yoshida; Ryosuke Tateishi; Yosuke Sugioka; Yukio Kume; Tomoko Okano; Tomomi Iwai; Hiroaki Gotoh; Sachiko Katoh; Atsushi Suzuki; Yukako Koike; Yutaka Yatomi; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2010-03-26       Impact factor: 7.527

2.  Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.

Authors:  Masato Yoneda; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Kento Imajo; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

3.  Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B.

Authors:  Fuat Ekiz; Osman Yüksel; Erdem Koçak; Barış Yılmaz; Akif Altınbaş; Sahin Çoban; Ilhami Yüksel; Oğuz Üsküdar; Seyfettin Köklü
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

4.  Full dose dipyridamole significantly improves thrombocytopenia in liver cirrhosis.

Authors:  G Luzzatto; F Fabris; G De Franchis; G E Gerunda; A Girolami
Journal:  Blut       Date:  1987-07

5.  Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B.

Authors:  M Sata; Y Yano; Y Yoshiyama; T Ide; R Kumashiro; H Suzuki; K Tanikawa
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

6.  Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma.

Authors:  Masaki Kaibori; Shoji Kubo; Hiroaki Nagano; Michihiro Hayashi; Seiji Haji; Takuya Nakai; Morihiko Ishizaki; Kosuke Matsui; Takahiro Uenishi; Shigekazu Takemura; Hiroshi Wada; Shigeru Marubashi; Koji Komeda; Fumitoshi Hirokawa; Yasuyuki Nakata; Kazuhisa Uchiyama; A-Hon Kwon
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

7.  Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C.

Authors:  Reiichiro Kondo; Hirohisa Yano; Osamu Nakashima; Ken Tanikawa; Yoriko Nomura; Masayoshi Kage
Journal:  J Gastroenterol       Date:  2012-08-22       Impact factor: 7.527

8.  Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension.

Authors:  Kent W Kercher; Alfredo M Carbonell; B Todd Heniford; Brent D Matthews; Dawn M Cunningham; Robert W Reindollar
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

9.  The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.

Authors:  Ipek Yonal; Binnur Pinarbası; Fehmi Hindilerden; Veysel Sabri Hancer; Meliha Nalcaci; Sabahattin Kaymakoglu; Reyhan Diz-Kucukkaya
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

10.  Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis.

Authors:  S P Lawrence; D C Lezotte; J D Durham; D A Kumpe; G T Everson; B M Bilir
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.